Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2
Bromocriptine is a sympatholytic agonist of dopamine receptors, which is now proposed for treatment of type 2 diabetes mellitus. In animal studies bromocriptine elevates the decreased levels of dopamine in hypothalamus and blocks excessive sympathetic innervations in central nervous system that resu...
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Endocrinology Research Centre
2011-12-01
|
| Reeks: | Ожирение и метаболизм |
| Onderwerpen: | |
| Online toegang: | https://www.omet-endojournals.ru/jour/article/view/5298 |